Hormone synthesis in human thyroglobulin: Possible cleavage of the polypeptide chain at the tyrosine donor site  by Marriq, Claudine et al.
Volume 242, number 2, 414-418 FEB 06666 January 1989 
Hormone synthesis in human thyroglobulin: possible cleavage of 
the polypeptide chain at the tyrosine donor site 
Claudine Marriq, Pierre-Jean Lejeune, Nicole Venot and Liliane Vinet 
UA 178 CNRS et U 38 INSERM, Biochimie Mkdicale, Fac;ltP de Midecine, 27 Bd Jean-Mot&n, 
13385 Marseille C~akx 05, France 
Received 3 October 1988; revised version received 4 November 1988 
At moderate iodination levels (20 iodine atoms/mol) human thyroglobulin (hTg) produces after reduction a hormone-rich 
peptide of 26 kDa which contains the preferential hormonogenic ‘acceptor’ tyrosine (Tyr 5) of the protein. The site of 
cleavage of the hTg chain was demonstrated by analysis of the 26 kDa tryptic hydrolysis products. It consistently ielded 
the peptide Gln-82-Val-129 which consequently made it possible to localize the hTg chain cleavage at tyrosine residue 
130. Evidence for tyrosine involvement in hTg cleavage during thyroid hormone formation supports the hypothesis that 
peptide bond cleavage would occur at the ‘donor’ tyrosine residue and suggests that tyrosine 130 would be the donor 
site reacting with the major hormone-forming acceptor site (Tyr 5) of hTg. 
Thyroglobulin; Hormone-forming acceptor site; Donor tyrosine residue; Peptide bond cleavage 
1. INTRODUCTION 
Thyroglobulin (Tg), the large dimeric 
iodoglycoprotein (2 x 330 kDa) of the thyroid 
gland, is the matrix within which thyroid hor- 
mones (T4 and T3) are synthesized. During hor- 
mone formation the intramolecular coupling 
reaction implies the fission of an iodotyrosyl 
residue (donor) next to its aromatic ring and a 
transfer of the iodophenolic moiety to the other 
iodotyrosine (acceptor). Besides coupling, other 
events take place in Tg molecule. In all vertebrate 
species tudied so far, small hormone-rich peptides 
(lo-30 kDa) are found after reduction of disulfide 
bridges of iodinated Tg [l-3]. It has been shown 
that at moderate iodination levels human Tg (hTg) 
produced after reduction a hormone-rich fragment 
Correspondenceaddress: C. Marriq, UA 178 CNRS et U 38 IN- 
SERM, Biochimie Mtdicale, Faculte de Mtdecine, 27 Bd Jean- 
Moulin, 13385 Marseille CCdex 05, France 
Abbreviations: hTg, human thyroglobulin; T4, thyroxine; Ts, 
3,5,3’-triiodothyronine; MIT, 3-iodotyrosihe; DIT, 3,5-diio- 
dotyrosine; TFA, trifluoroacetic acid 
which shows an apparent molecular mass of 
26 kDa in SDS-PAGE [4,5]. This hormonopeptide 
represents the N-terminal part of the hTg chain 
and contains the preferential hormonogenic accep- 
tor tyrosine residue (Tyr 5) of the protein [6], but 
the location of neither the corresponding donor 
site nor the cleaved peptide bond has been 
determined. 
Recent experiments [7,8] have indicated that this 
peptide bond cleavage might be part of the cou- 
pling reaction. So, taking into consideration that 
after fission of the iodotyrosine donor, the ‘lost 
side chain’ remains in the Tg polypeptide chain as 
a dehydroalanine residue [9,10], an unstable 
residue, we explored the possibility that the peptide 
bond cleavage would occur at the donor tyrosine 
residue. 
2. MATERIALS AND METHODS 
2.1. 26 kDa hormonopeptide preparation 
Poorly iodinated hTg (4 I atoms/mol) was purified from a 
human colloid goitre as in [ 1 l] and was in vitro iodinated as in 
[6] using the amount of KI necessary to incorporate about 20 I 
atoms/mol. Excess iodide was eliminated by dialysis. Iodinated 
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hTG was reduced and S-carboxymethylated [6], then filtered on 
a Biogel A-5 m column in 0.05 M T&Cl, 8 M urea, pH 7.6. 
The column effluent was pooled as 3 fractions I, II and III as 
previously described 161. Fraction III, containing the 26 kDa 
species, was further purified on a Biogel P-100 column in 0.1 M 
NH4HCOs without urea to avoid the possible coelution with 
contaminating species. 
2.2. Tryptic digestion 
26 kDa peptide (1% in 0.1 M NHdHCO,, pH 8.6) was 
digested for 4 h at 37°C with trypsin-TPCK (Worthington, 
Freehold, USA) at an enzyme to substrate ratio of 1: 25 (w/w). 
The digest was filtered on a column of Biogel P-30 in 0.05 M 
NHdHCO3. The different pools of peptides were lyophilized 
then dissolved in 0.05% TFA, 5% CH&N (solvent A) and sub- 
jected to high-performance liquid chromatography (HPLC) 
(Waters, Milford, USA) on a Select B reverse-phase column 
(4 x 250 mm, 5 pm particle size, Merck, Darmstadt, FRG). 
The elution was carried out for 5 min with solvent A then with 
a linear gradient from 0 to 55% of solvent B (0.05% TFA, 
CHpCN) for 70 min at room temperature and at a flow rate of 
0.8 ml/min. 
2.3. Partial acid hydrolysis 
It was accomplished by dissolving the peptide in 0.03 N HCl 
(approx. 1 mg/ml) and hydrolysing in an evacuated sealed tube 
a# 110VZ for 20 h. In these conditions aspartyl and asparaginyl 
beads were cleaved on both sides and free aspartic acid was 
liknusd [12]. The hydrolysate was desiccated, dissolved in 
0.0% TFA, 5% CH3CN and applied on a Lichrosorb RP-8 
colume (4 x 250 mm, 5 pm particle size, Merck). HPLC elution 
was carried out as above. 
2.4. Cwboxypeptidase P digestion 
TIM tryptic peptide T6 was dissolved (0.5 mg/ml) in 5 M 
urea, pyridine-acetate buffer, pH 4.0. Carboxypeptidase P
(Boehringer Mannheim, Germany) was used at an enzyme to 
substrate ratio of 1: 20 (w/w). The reaction mixture was in- 
cubated at 25°C for 120 min, dried and subjected to amino acid 
analysis. 
2.5. Other techniques 
Amino acid analyses were performed as in [13], manual 
microsequencing as in (141 and iodoamino acid estimation as in 
1151. 
3. RESULTS 
Previous investigations of 26 kDa hormonopep- 
tide had revealed that this fragment represents the 
N-terminal part of hTg [6] but the site of cleavage 
of hTg chain had not been determined since no 
amino acid was released after action of carbox- 
ypeptidases A, B or Y for digestion times 30 and 
120 min at pH 8.6 or 6.0 [ 13). Taking into account 
its apparent molecular mass (26 kDa) and the 
previous results of tryptic hydrolysis [ 131 it could 
be supposed that the fragment contained about 220 
amino acid residues; however, calculated on this 
basis, the amino acid composition of the peptide 
was not in good agreement with the composition 
predicted by cDNA sequence [la], especially re- 
garding the arginine residues. 
3.1. Tryptic peptide T6 from 26 kDa 
Purified 26 kDa was submitted to trypsin 
hydrolysis and the hydrolysate was filtered on a 
Biogel P-30 column, the first eluted fraction (A, 
fig.1) appeared to contain a single peptide in 
microsequence analysis and was analyzed without 
further purification. Its N-terminal sequence, 
determined after 8 steps of microsequencing, 
agreed very well with that of tryptic peptide T6 
predicted from cDNA sequence (fig.2), however, 
no amino acid was released after 120 min incuba- 
FR&N NUMBER 
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Fig. 1. Filtration on Biogel P-30 of the tryptic digest of 26 kDa 
peptide. About 2 mg protein were applied on a 1.5 x 65 cm 
column equilibrated and eluted in 0.05 M NI&HCOs; fraction 
volume, 1 ml; flow rate, 7 ml/h. Fractions A, B, C and D were 
the fractions pooled between the arrowheads. 
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Fig.2. Sequence of the first 171 amino acid residues from the N-terminal end of hTg as deduced from the nucleotide sequence of its 
mRNA according to [la]. (4) Predicted tryptic cleavages; (Tl-T6) peptides purified from the 26 kDa peptide; Tyr-5 (*), identified 
as T4 is the preferential hormonogenic residue acceptor of hTg [6]; the other tyrosine residues are boxed. 
tion with carboxypeptidase P. Furthermore, when 
compared with predicted T6, about 5 amino acid 
residues (Thr, Gly, Val, Tyr, Arg) were missing 
from the T6 peptide isolated from 26 kDa (table 
1). Predicted T6 contained 4 tyrosine and 5 valine 
residues (table 1). Considering that in the course of 
HCl hydrolysis some valyl bonds are not totally 
cleaved and that iodotyrosine residues are partially 
destroyed, the amino acid composition analysis 
alone was not sufficient to prove the C-terminal se- 
quence of tryptic peptide T6. Thus, the latter was 
submitted to partial acid hydrolysis to cleave only 
its Asp and Asn bonds and the derived acid pep- 
tides were separated by HPLC (fig.3). Their com- 
position, when compared with corresponding 
predicted sequences (table l), showed that Tyr-89, 
Tyr-97 and Tyr-107 were recovered respectively in 
peptide T6l, T62 and T63 and that T64, the pro- 
bable C-terminal peptide of T6, did not contain 
tyrosine at residue 130 but a valine residue. Conse- 
quently T6 purified from 26 kDa represents the 
hTg sequence Gln-82-Val-129 (fig.2). 
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3.2. C-terminal sequence of 26 kDa 
If the specificity of trypsin is taken into con- 
sideration, the formation of T6 (Gln-82-Val-129) 
after tryptic digestion of 26 kDa could be explain- 
ed by assigning to this fragment he position of the 
26 kDa C-terminal peptide. However we have 
previously shown that some aspecific cleavages by 
trypsin could occur in 26 kDa purified from highly 
iodinated hTg [ 131; so, to unambiguously locate 
T6 in the C-terminal position of 26 kDa, all other 
tryptic peptides were isolated from 26 kDa tryptic 
hydrolysate (fractions B, C and D, fig.1). The 
amino acid composition of each HPLC-purified 
peptide was compared with the predicted sequence 
from cDNA. Only the peptides representing the 
hTg sequence 1-81 (Tl-T5, fig.2) were recovered 
with a yield of 20-36%. The few others that do not 
belong to this part of the chain were obtained with 
a very poor recovery (never over 5%). 
These data show that the 26 kDa peptide is most 
likely the N-terminal fragment of hTg from Asn-1 
to Val-129 (fig.2). 
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Table 1 
Amino acid and iodoamino acid compositions of tyrosine-containing peptides purified from 26 kDa peptide 
Experimental procedures 
Tryptic hydrolysis T6 Partial acid hydrolysis T64 
of 26 kDa peptide predicted of tryptic peptide T6 predicted 
Peptide no. from cDNA from cDNA 
(see fig.2): T3 T6 sequence T6’ T62 T63 T64 sequence 
Amino acid 
residue positions 
(see fig.2) 
Amino acida 
CYS 
Asp 
Thr 
Ser 
Glu 
Pro 
ClY 
Ala 
Val 
Met 
lie 
Leu 
Tyr 
Phe 
His 
LYS 
Arg 
lodoamino acid 
MIT 
DIT 
T4 
26-49 82-? 82-133 82-90 95-102 107-112 KU-? 124-133 
2.2 
4.2 
1.0 
1.2 
6.8 
1.4 
2.2 
2.3 
2.1 
1.0 
1.1 
1.0 
3.7 
6.0 
2.3 
4.1 
8.9 
1.9 
3.2 
2.0 
3.9 
0.7 
1.9 
3.6 
2.3 
0.1 
0.6 
0.2 
0.5 
0.08 
0.0 
4 
6 
3 
4 
9 
2 
4 
2 
5 
1 
2 
4 
4 
0.5 
0.8 
1.0 
1.4 1.3 
0.5 
1.2 
1.6 
2.0 1.0 
1.1 0.6 
0.5 
1 
1.2 2.0 2 
0.9 2 
1.0 0.4 1 
1.0 1.0 1 
0.4 1 
1.1 1 
1 
0.3 
0.0 
0.0 
a The amino acid composition of T3, T6, T6’. T6’. T6’ and T64 was normalized respectively to Arg: 1, Asp: 6, Leu: 
2, Leu: 1, Ala: 1 and Glu: 2 
I ’ 
0 20 40 60 
TIma (mln) 
Fig.3. HPLC analysis of the acid hydrolysate of the tryptic 
peptide T6. Approx. 190rg protein were injected into a 
Lichrosorb RP-8 column. The elution was carried out as 
described in section 2. The elution positions of the tyrosyl acid 
peptides (T6’, T6’, T6’ and T64) are indicated. 
4. DISCUSSION 
If the 26 kDa peptide is considered as 
originating from the cleavage of the 
valyl-129-tyrosyl-130 bond, it is difficult to ex- 
plain why carboxypeptidases, used herein, under 
many different conditions, fail to hydrolyse the C- 
terminal residues. On the other hand, the presence 
of an unusual residue at the C-terminal end of 
26 kDa (or T6) may explain these results. Thus, it 
is tempting to suggest hat the cleavage occurs at 
the dehydroalanine residue, the ‘lost side chain’ of 
the donor tyrosine-130. 
We have recently shown that the peptide 
Asn-l-Met-171 isolated from a poorly iodinated 
hTg was able to form thyroid hormones at Tyr-5 
when submitted to enzymatic iodination in vitro 
417 
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[ 17,181. This observation demonstrated the 
presence of a donor residue in the sequence 1-171. 
Among the 6 tyrosine residues present in this part 
of the molecule, 5 have been recovered from the 
26 kDa hormonopeptide: Tyr-5, the preferential 
acceptor site of hTg [6], Tyr-29 recovered in tryptic 
peptide Tr, Tyr-89 in peptide T6l, Tyr-97 (as 
tyrosine and MIT) in T62 and Tyr-107 in T63 (table 
1). Consequently the 6th tyrosine residue, Tyr-130, 
would be a very good candidate for the donor site 
reacting with the major hormone-forming acceptor 
site (Tyr-5) of hTg. 
It is difficult to know if the cleavage is actually 
part of the coupling reaction in vivo. Recent results 
of Kondo et al. [lo] suggest hat dehydroalanine 
residues remain in the Tg chain after hormone for- 
mation: it is possible that the cleavage occurs dur- 
ing the in vitro reduction step of iodinated Tg. 
Why this peptide containing 129 or 130 amino acid 
residues behaves in SDS-PAGE like a 26 kDa pep- 
tide is still unclear. A possible dimerization or the 
influence of the oligosaccharide chains identified 
at positions 57 and 91 [19] could be evoked. 
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